IRIS
RUTIGLIANO, MONICA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.386
AS - Asia 1.478
EU - Europa 1.122
SA - Sud America 334
AF - Africa 69
AN - Antartide 1
OC - Oceania 1
Totale 6.391
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.324
SG - Singapore 577
CN - Cina 359
IT - Italia 283
BR - Brasile 266
SE - Svezia 194
RU - Federazione Russa 172
HK - Hong Kong 163
VN - Vietnam 139
DE - Germania 128
FI - Finlandia 74
FR - Francia 69
GB - Regno Unito 65
IN - India 41
CA - Canada 37
UA - Ucraina 37
NL - Olanda 28
BD - Bangladesh 26
ID - Indonesia 23
AR - Argentina 20
MX - Messico 20
BE - Belgio 19
JP - Giappone 19
TR - Turchia 18
CO - Colombia 17
PK - Pakistan 17
SA - Arabia Saudita 17
ZA - Sudafrica 17
IQ - Iraq 16
CI - Costa d'Avorio 15
VE - Venezuela 12
ES - Italia 10
UZ - Uzbekistan 10
IR - Iran 6
MA - Marocco 6
PH - Filippine 6
PL - Polonia 6
TN - Tunisia 6
AT - Austria 5
IE - Irlanda 5
LT - Lituania 5
MY - Malesia 5
AE - Emirati Arabi Uniti 4
BO - Bolivia 4
DZ - Algeria 4
EC - Ecuador 4
KR - Corea 4
NP - Nepal 4
AO - Angola 3
AZ - Azerbaigian 3
CL - Cile 3
EG - Egitto 3
ET - Etiopia 3
HU - Ungheria 3
KE - Kenya 3
OM - Oman 3
PT - Portogallo 3
TH - Thailandia 3
UY - Uruguay 3
BY - Bielorussia 2
CZ - Repubblica Ceca 2
HN - Honduras 2
IL - Israele 2
JO - Giordania 2
KG - Kirghizistan 2
LB - Libano 2
PA - Panama 2
PE - Perù 2
PY - Paraguay 2
RE - Reunion 2
RO - Romania 2
SY - Repubblica araba siriana 2
ZW - Zimbabwe 2
AL - Albania 1
AM - Armenia 1
AQ - Antartide 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
CG - Congo 1
GA - Gabon 1
GE - Georgia 1
GY - Guiana 1
HR - Croazia 1
KZ - Kazakistan 1
LU - Lussemburgo 1
LV - Lettonia 1
LY - Libia 1
MK - Macedonia 1
MT - Malta 1
NG - Nigeria 1
PS - Palestinian Territory 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
UG - Uganda 1
Totale 6.391
Salva come PNG Salva come JPEG
Città #
Ashburn 453
Fairfield 352
Singapore 332
Chandler 259
Woodbridge 249
Seattle 176
Houston 172
Hong Kong 162
San Jose 150
Beijing 146
Cambridge 145
Nyköping 144
Wilmington 127
Ann Arbor 122
Bari 98
New York 77
Los Angeles 69
Jacksonville 66
Munich 54
Ho Chi Minh City 50
Dallas 42
Lauterbourg 42
Roxbury 42
Lawrence 40
São Paulo 33
Nanjing 29
Helsinki 27
Princeton 27
Council Bluffs 26
Des Moines 25
Hanoi 24
Brooklyn 23
Inglewood 23
Santa Clara 21
Dearborn 20
Boardman 19
Brussels 18
Buffalo 18
Toronto 18
Jakarta 17
Chicago 16
Dong Ket 16
Frankfurt am Main 16
Turku 16
Abidjan 15
London 15
Orem 14
Rome 14
Shenyang 13
San Diego 12
Falkenstein 11
Manduria 11
Nanchang 11
The Dalles 11
Caracas 10
Moscow 10
Rio de Janeiro 10
Tianjin 10
Tokyo 10
Atlanta 9
Changsha 9
Columbus 9
Hebei 9
Indianapolis 9
Mexico City 9
Phoenix 8
Pune 8
Amsterdam 7
Boston 7
Brasília 7
Johannesburg 7
Nuremberg 7
Paris 7
Redwood City 7
San Francisco 7
Tashkent 7
Belo Horizonte 6
Chennai 6
Curitiba 6
Milan 6
Montreal 6
Riyadh 6
Augusta 5
Baghdad 5
Bitonto 5
Bogotá 5
Catania 5
Dublin 5
Guangzhou 5
Haiphong 5
Hefei 5
Jeddah 5
Jiaxing 5
Kunming 5
Noicattaro 5
Stockholm 5
Biên Hòa 4
Campinas 4
Casamassima 4
Delhi 4
Totale 4.433
Salva come PNG Salva come JPEG
Nome #
Renal progenitor cells revert LPS-induced endothelial-to-mesenchymal transition by secreting CXCL6, SAA4, and BPIFA2 antiseptic peptides 225
Metabolomic profile of glycolysis and the pentose phosphate pathway identifies the central role of glucose-6-phosphate dehydrogenase in clear cell-renal cell carcinoma. 218
Integrated multi-omics characterization reveals a distinctive metabolic signature and the role of NDUFA4L2 in promoting angiogenesis, chemoresistance, and mitochondrial dysfunction in clear cell renal cell carcinoma 205
Loss of STK11 expression is an early event in prostate carcinogenesis and predicts therapeutic response to targeted therapy against MAPK/p38. 202
Increased Expression of the Autocrine Motility Factor is Associated With Poor Prognosis in Patients With Clear Cell-Renal Cell Carcinoma 201
Activation of the kynurenine pathway predicts poor outcome in patients with clear cell renal cell carcinoma 201
Serum sarcosine increases the accuracy of prostate cancer detection in patients with total serum PSA less than 4.0 ng/ml. 191
Isolation and characterization of cancer stem cells in renal cell carcinoma. 186
Urinary RKIP/p-RKIP is a potential diagnostic and prognostic marker of clear cell renal cell carcinoma 182
Rapamycin-Induced Hypophosphatemia and Insulin Resistance Are Associated With mTORC2 Activation and Klotho Expression 169
Renal Cell Carcinoma: A Study through NMR-Based Metabolomics Combined with Transcriptomics 167
Soluble Serum αklotho Is a Potential Predictive Marker of Disease Progression in Clear Cell Renal Cell Carcinoma 163
Pre-existing Type 2 Diabetes Mellitus Is an Independent Risk Factor for Mortality and Progression in Patients With Renal Cell Carcinoma. 160
Uridine and pyruvate protect T cells’ proliferative capacity from mitochondrial toxic antibiotics: a clinical pilot study 153
Microvascular density, macrophages, and mast cells in human clear cell renal carcinoma with and without bevacizumab treatment 150
Spondin-2, a Secreted Extracellular Matrix Protein, Is a Novel Diagnostic Biomarker for Prostate Cancer. 145
SERUM SARCOSINE INCREASES THE ACCURACY OF PROSTATE CANCER DETECTION IN LOW RANGE PSA 139
Serum sarcosine is a risk factor for progression and survival in patients with metastatic castration-resistant prostate cancer. 136
Emerging urinary markers of renal injury in obstructive nephropathy. 133
Diagnostic and prognostic role of preoperative circulating CA 15-3, CA 125, and beta-2 microglobulin in renal cell carcinoma. 133
A CLUSTER OF PROTEINS SECRETED BY HUMAN RENAL STEM/PROGENITOR CELLS (ARPCS) PROVIDE A NOVEL STRATEGY TO REVERT ENDOTHELIAL DYSFUNCTION AND RENAL INJURY IN SEPSIS-INDUCED ACUTE KIDNEY INJURY (AKI) 126
Cryopreserved Penile Tunica Albuginea for Allotransplantation: A Morphological and Ultrastructural Investigation. 125
Analisi dei fattori critici nello studio MALDI-TOF del profilo peptidico urinario in soggetti sani e con cancro alla prostata 123
Optimization of analytical and pre-analytical conditions for MALDI-TOF-MS human urine protein profiles 123
The three-gene signature in urinary extracellular vesicles from patients with clear cell renal cell carcinoma 119
DIABETES MELLITUS IN RENAL CELL CARCINOMA: ROLE OF OGG1 AND TUBERIN 119
DIABETES MELLITUS IS A RISK FACTOR FOR RECURRENCE AND MORTALITY IN PATIENTS WITH RENAL CELL CARCINOMA . 119
Metabolomic profiling for the identification of novel diagnostic markers in prostate cancer 110
The Anti-Fibrotic Effect of Mycophenolic Acid-Induced Neutral Endopeptidase 108
B3 Adrenergic Receptor Agonist Mirabegron Increases AQP2 and NKCC2 Urinary Excretion in OAB Patients: A Pleiotropic Effect of Interest for Patients with X-Linked Nephrogenic Insipidus 105
Regulation of TGF-beta 1 expression by Androgen Deprivation Therapy of prostate cancer 101
LAMININA 5 COME MARKER NELLA DIAGNOSI E NELLA PROGNOSI DEL CARCINOMA UROTELIALE DELLA VESCICA 98
ASSOCIATION OF N-ACETYLTRANSFERASE 2 POLYMORPHISM WITH RISK FACTORS IN UROTHELIAL CANCER. 97
MP067 MICRORNA PROFILING USING NEXT-GENERATION SEQUENCING IN RENAL CANCER STEM CELLS: A NEW REGULATORY MECHANISM 96
MUC1 Expression Affects the Immunoflogosis in Renal Cell Carcinoma Microenvironment through Complement System Activation and Immune Infiltrate Modulation 95
DIABETES MELLITUS IS A RISK FACTOR FOR PROGRESSION IN RENAL CELL CARCINOMA 93
RENAL CELL CARCINOMA: DOES TRANSCRIPTIONAL DEREGULATION OF ADULT RENAL STEM/PROGENITOR CELLS LEAD TO ONCOGENESIS? 93
Renal Cell Carcinoma as a Metabolic Disease: An Update on Main Pathways, Potential Biomarkers, and Therapeutic Targets 91
Ischemia-Reperfusion Injury in Kidney Transplantation: Mechanisms and Potential Therapeutic Targets. 90
THE DIAGNOSTIC ROLE OF CA 15-3, CA 125 AND BETA2-MICROGLOBULIN IN RENAL CELL CARCINOMA 88
null 86
Metabolomic profiling for the identification of novel diagnostic markers and therapeutic targets in prostate cancer: an update 84
CTR2 Identifies a Population of Cancer Cells with Stem-Like Features in Patients with Clear Cell Renal Cell Carcinoma. 81
Metabolomic Approaches for Detection and Identification of Biomarkers and Altered Pathways in Bladder Cancer 81
MUC1 Tissue Expression and Its Soluble Form CA15-3 Identify a Clear Cell Renal Cell Carcinoma with Distinct Metabolic Profile and Poor Clinical Outcome 81
LOSS OF LKB1 EXPRESSION IS AN EARLY MOLECULAR EVENT IN PROSTATE CARCINOGENESIS 77
null 74
To007 Adult Renal Stem/progenitor Cells Express Long Non-coding Rnas Involved In Wnt And The Bmp Signaling Pathway 68
SP168 ARPCS CAN REVERT LPS-INDUCED ENDOTHELIAL-TO-MESENCHYMAL TRANSITION OF ENDOTHELIAL CELLS 65
null 61
Complement System and the Kidney: Its Role in Renal Diseases, Kidney Transplantation and Renal Cell Carcinoma 57
The Role of MUC1 in Renal Cell Carcinoma. Biomolecules. 55
null 49
null 46
null 36
null 16
Totale 6.595
Salva come PNG Salva come JPEG
Categoria #
all - tutte 26.168
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.168
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021173 0 0 0 0 0 0 0 0 0 64 69 40
2021/2022375 22 30 8 13 18 26 23 19 20 50 65 81
2022/2023619 96 106 48 63 48 86 4 65 68 6 16 13
2023/2024242 22 40 10 18 27 86 6 5 2 9 6 11
2024/20251.188 30 22 69 59 36 98 190 120 44 67 155 298
2025/20262.056 408 122 114 206 320 145 239 77 223 202 0 0
Totale 6.595